Skip to main content

NCI Partners with Seoul University on Clinical Proteomics

NEW YORK (GenomeWeb News) – The National Cancer Institute said today that it has struck an agreement with a South Korean hospital to partner on the development and application of proteomic tools in a clinical environment.

NCI's Office of Cancer Clinical Proteomics Research (OCCPR) and Seoul National University Cancer Hospital (SNUCH) have inked a memorandum of understanding under which SNUCH will test proteomic technologies, standards, workflows, and protein assays developed by NCI's Clinical Proteomic Tumor Analysis Consortium (CPTAC).

CPTAC was created to identify proteins linked to alterations in cancer genomes by leveraging data from initiatives such as the Cancer Genome Atlas to eventually link genotypes and proteotypes with cancer phenotypes.

The research the partners plan to undertake through this agreement will address how proteomic technologies may be applied in active clinical settings, and they will seek to generate, interpret, and translate data for physicians and patients. They also will examine the ethical, legal, and psychosocial implications of using proteomic data in the clinic.

Also under the agreement, OCCPR and SNUCH will share protein targets that are associated with cancer, train and exchange scientists and information, and disseminate new products and data to the research community.

The new MOU is an extension of an agreement from 2010, under which the NCI and the Korean Institute of Science and Technology worked to optimize proteomic technologies and implement standards for large-scale international programs.

The Scan

Response Too Slow, Cautious

A new report criticizes the global response to the threat of the COVID-19 pandemic, Nature News reports.

Pushed a Bit Later

Novavax has pushed back its timeline for filing for authorization for its SARS-CoV-2 vaccine, according to Bloomberg.

AMA Announces Anti-Racism Effort

The Associated Press reports that the American Medical Association has released a plan to address systemic racism in healthcare.

Nucleic Acids Research Papers on miRMaster 2.0, MutationTaster2021, LipidSuite

In Nucleic Acids Research this week: tool to examine small non-coding RNAs, approach to predict ramifications of DNA variants, and more.